Company / AR per Share
Seres Therapeutics, Inc. AR per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.02
FY2025
5-year range
$0.02 / $0.13
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.04 to $0.02 over the past 6 years.
Based on SEC 10-K filings.
0.02 in FY2025.
Declined from $0.04 to $0.02 over the past 6 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -32.9%
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.18 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $0.13 | +206.9% |
| FY2019 | $0.04 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 24, 2026